Manuscripts
Showing 1556 manuscripts.
Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants.
Citation
Edmund Capparelli, John L. Sullivan, Lynne M. Mofenson, Elaine Margaret Smith, Bobbie L. Graham, Bobbie L. Graham, Paula Britto, Mark I. Becker, Diane Holland, James D. Connor, Katherine Luzuriaga. Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants.. Pediatric Infectious Disease Journal. 2001. 20: 746-51.Year
2001
Journal
Pediatric Infectious Disease Journal
Human Immunodeficiency Virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.
Citation
Sandra K. Burchett, Lisa M. Frenkel, Elizabeth (Betsy) J. McFarland, Ram Yogev, William Borkowsky, Francis Gigliotti, Terence Fenton, Katherine Luzuriaga, Diane W. Wara, Robert Livingston, James McNamara, Pearl Samson, Minhee Kang, Lynne M. Mofenson, Coleen K. Cunningham, Anne-Marie Duliege, Faruk Sinangil, Stephen A. Spector, Eleanor Jimenez, Yvonne J. Bryson. Human Immunodeficiency Virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.. Journal of Infectious Diseases. 2001. 184: 1331-1335.Year
2001
Journal
Journal of Infectious Diseases
Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.
Citation
Steven Gortmaker, Michael Hughes, Joseph S. Cervia, Rebecca Oyomopito, Michael T. Brady, James M. Oleske, George M. Johnson, George Seage, Lin-Ye Song, Wayne M. Dankner, Wayne M. Dankner, James M. Oleske. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.. New England Journal of Medicine. 2001. 21: 1522-1528. PMID: 11794218Year
2001
Journal
New England Journal of Medicine
ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1
Citation
Laura Smeaton, Victor DeGruttola, Gregory K. Robbins, Robert Shafer. ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1. Controlled Clinical Trials. 2001. 22: 142-59.Year
2001
Journal
Controlled Clinical Trials
Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients
Citation
Hernan Valdez, Julia A. Metcalf, Barbara Gripshover, Jeffrey M. Jacobson, Ronald T. Mitsuyasu, Michael M. Lederman. Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients. AIDS. 2001. 15: 661-2.Year
2001
Journal
AIDS
Glucose disorders associated with HIV and its drug therapy
Citation
Helene Hardy, Lori Esch, Gene D. Morse. Glucose disorders associated with HIV and its drug therapy. Annals of Pharmacotherapy. 2001. 35: 343-51.Year
2001
Journal
Annals of Pharmacotherapy
Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus
Citation
Catherine Leport, J. Franck, Genevieve Chene, F. Derouin, JL Ecobichon, Sophie Pueyo, Jose Miro, Benjamin J. Luft, Philippe Morlat, H. Dumon. Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus. Clinical and Diagnostic Laboratory Immunology. 2001. 8: 579-84.Year
2001
Journal
Clinical and Diagnostic Laboratory Immunology
Plasma carnitine in HIV-associated neuropathy
Citation
David M. Simpson, David Katzenstein, Bettina Haidich, David Millington, Constantin Yiannoutsos, Giovanni Schifitto, Justin C. McArthur. Plasma carnitine in HIV-associated neuropathy. AIDS. 2001. 15: 2207-8.Year
2001
Journal
AIDS
Population pharmacokinetics of dapson in children with human immunodeficiency virus infection.
Citation
Mark Mirochnick, Ellen Rae Cooper, Edmund Capparelli, Kenneth McIntosh, Jane C. Lindsey, Jing Xu, David P. Jacobus, Lynne M. Mofenson, Vincent R. Bonagura, Sharon Appelbaum Nachman, Ram Yogev, Stephen A. Spector. Population pharmacokinetics of dapson in children with human immunodeficiency virus infection.. Clinical Pharmacology & Therapeutics. 2001. 1: 24-32.Year
2001
Journal
Clinical Pharmacology & Therapeutics
Maternal and Fetal Clinical Effects Of Didanosine (ddl) Use In Pregnancies Complicated By HIV-1 Infection
Citation
Elizabeth Livingston, Arlene D. Bardeguez, Jorge Gandia, Mary Jo O'Sullivan, Sharon Huang, Ross E. McKinney, W. N.P. Herbert, Pamela A. Clax, Yi Wang, Sheran Patel, Ruth E. Dickover, Jashvant D. Unadkat. Maternal and Fetal Clinical Effects Of Didanosine (ddl) Use In Pregnancies Complicated By HIV-1 Infection. American Journal of Obstetrics and Gynecology. 2001.Year
2001
Journal
American Journal of Obstetrics and Gynecology